Zoono CEO quits as financial woes mount

Zoono CEO quits as financial woes mount
Zoono's antiviral solution got some heavy use through the pandemic. (Image: Getty)
Denise McNabb
Zoono Group’s chief executive, Barry Woolcott, has resigned seven months into the job. He will leave the troubled New Zealand-based and Australian stock exchange (ASX) listed manufacturer of a proprietary long-life hand and surface sanitiser in January.His departure follows a review of the company’s overhead structure after Zoono reported an annual loss of $12.1 million for the June 2022 year and negative net operating cashflow of $2m in the first quarter to Sept 30. Administration and corporate costs of $1.5m exceeded cus...

More Markets

Fisher & Paykel Healthcare drives sharemarket up
Markets Market Close

Fisher & Paykel Healthcare drives sharemarket up

The S&P/NZX 50 Index closed up 0.61% or 81.576 points to 13,562.01.

Tom Raynel 26 Nov 2025
Rakon stock-price climbs ahead of result
Markets

Rakon stock-price climbs ahead of result

Rakon shares rose almost 9% on Wednesday but spiked even higher during the day.

Fisher Funds backs Summerset in rejecting covenant waiver claims
Markets

Fisher Funds backs Summerset in rejecting covenant waiver claims

Summerset is compliant with all lending covenants and obligations.

Rebecca Howard 26 Nov 2025
Critical minerals miner plans 2026 NZX listing
Primary Sector

Critical minerals miner plans 2026 NZX listing

The company plans to raise $20m from retail investors in mid-2026.

Pattrick Smellie 26 Nov 2025